Video

Expert Discusses How DMT Differs From Other Psychedelic Medicines

Carol Routledge, PhD, chief medical and scientific officer at Small Pharma, discusses DMT, how it differs from other psychedelic medicines, and what the future holds for DMT-assisted treatments.

Carol Routledge, PhD, chief medical and scientific officer at Small Pharma, discussed DMT, how it differs from other psychedelic medicines, and what the future holds for DMT-assisted treatments.


She spoke about the benefits of DMT, what the treatment targets are, and early research of the drug.

Related Videos
Related Content
ASHP Midyear: Automated Compounding Workflows and Comprehensive Record-Keeping Reduce Errors
December 19th 2024

ASHP Midyear: Automated Compounding Workflows and Comprehensive Record-Keeping Reduce Errors

Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments
November 25th 2024

Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments

Selma Mitchie, PharmD
November 21st 2024

Advancing Compounding Standards: Insights From the USP Compounding Implementation Workshop

Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer
October 28th 2024

Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer

Pharmacist Spotlight: Julie Yang, PharmD, CSP, BCPS
November 14th 2024

Pharmacist Spotlight: Julie Yang, PharmD, CSP, BCPS

Immunization, Flu, Pharmacy, Community, Influenza | Image Credit: anon - stock.adobe.com
November 12th 2024

Pharmacists Combat Flu Misinformation and Expand Vaccine Access

Ashley Gallagher, Associate Editor